These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27303572)

  • 1. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
    Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
    Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda.
    Musisi E; Wamutu S; Ssengooba W; Kasiinga S; Sessolo A; Sanyu I; Kaswabuli S; Zawedde J; Byanyima P; Kia P; Muwambi W; Toskin DT; Kigozi E; Walbaum N; Dombay E; Legrady MB; Ssemambo KD; Joloba M; Kuchaka D; Worodria W; Huang L; Gillespie SH; Sabiiti W
    Lancet Microbe; 2024 Apr; 5(4):e345-e354. PubMed ID: 38458206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.
    Hermans SM; Babirye JA; Mbabazi O; Kakooza F; Colebunders R; Castelnuovo B; Sekaggya-Wiltshire C; Parkes-Ratanshi R; Manabe YC
    BMC Infect Dis; 2017 Jun; 17(1):433. PubMed ID: 28622763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
    PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert
    Zawedde-Muyanja S; Manabe YC; Sewankambo NK; Nakiyingi L; Nakanjako D
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1475-1480. PubMed ID: 30606320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
    Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
    PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study.
    Lisboa M; Fronteira I; Colove E; Nhamonga M; Martins MDRO
    BMC Infect Dis; 2019 Jan; 19(1):18. PubMed ID: 30616533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
    Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
    BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
    PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.
    Naidoo P; Dunbar R; Lombard C; du Toit E; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2016; 11(3):e0150487. PubMed ID: 26930400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
    PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.
    Mbelele PM; Aboud S; Mpagama SG; Matee MI
    BMC Infect Dis; 2017 Dec; 17(1):808. PubMed ID: 29284421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.